Psychiatric Disorders
48
10
11
19
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
1 terminated out of 48 trials
95.0%
+8.5% vs benchmark
6%
3 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (48)
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
French Validation of the Recovery Assessment Scale (RAS-FR)
Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders
The WARM Study is a Pilot Study That Aims to Investigate the Impact of Environmental Factors on Acute and Chronic Wounds, Mental Illness, and Social Factors Among People Experiencing Housing Emergencies in Augsburg.
Improving Mental Health Treatment for Individuals in Crisis Interacting With the Criminal-Legal System
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
Virtual Reality Schema Therapy Exercises With Parent and Child Modes
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
Psychiatric Manifestations Associated With Behcet's Disease
Qigong Relaxation Exercise
The Effect of Art Therapy on Disease Severity and Anxiety Levels in Inpatients at a Psychiatry Clinic
The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome
Chewing Gum as a Therapeutic Intervention for the Management of Hypersalivation
Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders
Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia